HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA associations with Hashimoto's thyroiditis.

Abstract
There is disagreement over the HLA-DR associations of Hashimoto's (goitrous) thyroiditis. We have studied 86 English Caucasian patients with this condition whose DR types were determined by restriction fragment polymorphism analysis. HLA-DR3 was significantly more frequent in these patients than in 100 controls (chi 2 = 7.09; P less than 0.01). The relative risk was 2.23 and aetiological fraction 0.29. HLA-DPB and DQB alleles were analysed in a proportion of these subjects by enzymatic DNA amplification and oligonucleotide probing. The only significant finding was an excess of HLA-DQw2 (in linkage disequilibrium with DR3) in the Hashimoto group (chi 2 = 7.43, P less than 0.007). These results do not support a difference between goitrous and atrophic thyroiditis based on respective associations with HLA-DR5 and DR3, but confirm a recent study in which HLA-DR3 was associated with Hashimoto's thyroiditis. However, it is possible that genes telomeric to DR3 may be involved in determining which type of thyroiditis a patient with autoimmune hypothyroidism develops.
AuthorsN Tandon, L Zhang, A P Weetman
JournalClinical endocrinology (Clin Endocrinol (Oxf)) Vol. 34 Issue 5 Pg. 383-6 (May 1991) ISSN: 0300-0664 [Print] England
PMID1676351 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-D Antigens
  • HLA-DQ Antigens
  • HLA-DQ2 antigen
  • HLA-DR3 Antigen
Topics
  • Female
  • HLA-D Antigens (analysis)
  • HLA-DQ Antigens (analysis)
  • HLA-DR3 Antigen (analysis)
  • Humans
  • Linkage Disequilibrium (genetics)
  • Male
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Thyroiditis, Autoimmune (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: